Scholars Central

Conference abstractPublished 23 Sep 2013

Patents and biosimilars: Ensuring strong intellectual property protection

Authors: Sandra Frantzen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biosimilar technologies are at the forefront of both science and the law with intellectual property issues playing a large strategic role. Understanding intellectual property issues is not always easy and biotechnologies sometimes raise challenges regarding how to manage and protect intellectual property rights. The law regarding how biotechnology can be protected is constantly evolving and it is important to keep abreast of ongoing developments. This presentation is intended to familiarize the audience with current patent issues facing those in the biosimilar space as well as legal issues presented by the Biologics Price Competition and Innovation Act.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Sandra Frantzen”